↓ Skip to main content

Impact of Smoking on Response to the First-Line Treatment of Advanced ALK-Positive Non-Small Cell Lung Cancer: A Bayesian Network Meta-Analysis

Overview of attention for article published in Frontiers in Pharmacology, May 2022
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

twitter
4 X users

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
17 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Impact of Smoking on Response to the First-Line Treatment of Advanced ALK-Positive Non-Small Cell Lung Cancer: A Bayesian Network Meta-Analysis
Published in
Frontiers in Pharmacology, May 2022
DOI 10.3389/fphar.2022.881493
Pubmed ID
Authors

Kehai Lin, Jie Lin, Zhong Huang, Jiding Fu, Qi Yi, Jiazuo Cai, Muhammad Khan, Yawei Yuan, Junguo Bu

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 17 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 17 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 2 12%
Student > Doctoral Student 1 6%
Unspecified 1 6%
Student > Master 1 6%
Unknown 12 71%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 2 12%
Medicine and Dentistry 2 12%
Immunology and Microbiology 1 6%
Unspecified 1 6%
Unknown 11 65%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 May 2022.
All research outputs
#15,156,937
of 23,312,088 outputs
Outputs from Frontiers in Pharmacology
#5,446
of 16,764 outputs
Outputs of similar age
#231,765
of 442,571 outputs
Outputs of similar age from Frontiers in Pharmacology
#321
of 1,201 outputs
Altmetric has tracked 23,312,088 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 16,764 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.0. This one has gotten more attention than average, scoring higher than 60% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 442,571 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 44th percentile – i.e., 44% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,201 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.